Efficacy and Safety Study of E2007 in Migraine Prophylaxis

NCT00154063 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Prophylaxis

Interventions

DRUG: E2007
OTHER: Placebo

Sponsor

Eisai Inc.